Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CDR2 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA553741
Description
Immunogen sequence: GVEKLVPDSL YVPFKEPSQS LLEEMFLTVP ESHRKPLKRS SSETILSSLA GSDIVKGHEE TCIRRAKAVK QRGISLLHEV DTQYSALKVK YEELLKKCQE EQDSLSHKAV QTSRAAAKDL TGV Highest antigen sequence identity to the following orthologs: Mouse - 88%, Rat - 88%.
Using anti-Yo antibodies, three genes have been cloned (CDR 1-3). CDR2 suppresses the transcriptional activity and DNA binding of nuclear factor-kappa B by an unknown mechanism. The neuron specific expression of CDR2 is regulated by a post-transcriptional mechanism.
Specifications
CDR2 | |
Polyclonal | |
Unconjugated | |
CDR2 | |
AA617262; CDR2; CDR62; cerebellar degeneration related protein 2; cerebellar degeneration-related 2; cerebellar degeneration-related protein 2; cerebellar degeneration-related protein 2, 62kDa; major Yo paraneoplastic antigen; MGC128861 protein; paraneoplastic cerebellar degeneration-associated antigen; PCD17; RGD1310578; Yo; Yo paraneoplastic antigen | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
1039 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
0.3 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q01850 | |
CDR2 | |
Recombinant protein corresponding to Human CDR2. Recombinant protein control fragment (Product #RP-91639). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction